İstanbul University
İstanbul Üniversitesi
“ Building Bridges Between The Belgian Biopharma Ecosystem And Türkiye ”” Program Held At Istanbul University With The Participation Of Her Majesty Queen Mathilde Of Belgium
event Published on: 13 May 2026
visibility 118 views
event 13 May 2026
visibility 118
“ Building Bridges Between The Belgian Biopharma Ecosystem And Türkiye ”” Program Held At Istanbul University With The Participation Of Her Majesty Queen Mathilde Of Belgium

The program titled “Building Bridges between the Belgian Biopharma Ecosystem and Türkiye” was organized under the hosting of our University and held on 12 May 2026 at the Blue Hall of the Istanbul University Rectorate with the participation of Her Majesty Queen Mathilde of Belgium.


 The program was attended by Minister of Family and Social Services Mahinur Özdemir Göktaş, our Rector Prof. Dr. Osman Bülent Zülfikar and the senior administration of our University, as well as numerous guests from academia, the healthcare sector and the biopharma industry.


Delivering the opening speech of the program, Istanbul University Vice-Rector Prof. Dr. Rabia Nergiz Dağoğlu Sakin stated that more than 700 joint academic studies had been carried out with Belgium over the past five years in critical fields such as rare diseases, genetics and oncology. Drawing attention to the multidisciplinary research capacity of the Department and Laboratory of Rare Diseases within Istanbul University, Prof. Dr. Dağoğlu Sakin emphasized that human beings and hope should always remain at the center of scientific progress and highlighted the importance of collaborations to be established between Türkiye and Belgium in the fields of life sciences and biopharma.


Representative of the Belgian Health and Biotechnology Delegation Yves Verschueren, in his presentation titled “Remarks on the Belgian Biopharma Ecosystem,” introduced Belgium’s research and development oriented ecosystem and underlined the strategic partnerships that could be established with Türkiye. Emphasizing Belgium’s global leadership in biotechnology and clinical research, Verschueren stated that projects to be developed among universities, academia and industry would offer next-generation healthcare solutions and concrete collaboration opportunities for both countries.


In the session titled “Remarks on the Turkish Biopharma Ecosystem,” Pharmaceutical Manufacturers Association of Turkey (IEIS) Secretary General Savaş Malkoç shared his evaluations regarding Türkiye’s biopharma ecosystem. In his speech, Malkoç addressed Türkiye’s high domestic production rate of 93 percent in pharmaceutical manufacturing, the substantial increase in research and development expenditures, and the production of biotechnological medicines through domestic capabilities with the aim of transforming Türkiye into a regional export hub, emphasizing the country’s potential in the field of biopharma.


Within the scope of the program, a session titled “From Strategic Partnerships to Drug Discovery – A Success Story: How UCB Improves the Lives of Turkish Patients Affected by Rare Diseases” was also held. During the session, Prof. Dr. Hacer Durmuş Tekçe and UCB CEO Mr. Jean Christophe Tellier shared their evaluations on the challenges encountered in achieving accurate diagnosis in rare diseases, the critical importance of early diagnosis for the quality of life of patients and caregivers, and the strategic role played by clinical innovation, Türkiye’s academic competence and “Real World Evidence” (RWE) in the treatment of ultra-rare diseases such as TK2D deficiency.


Vice-President of the Wallonia Government Pierre-Yves Jeholet, in his speech titled “Building Bridges between the Belgian Biopharma Ecosystem and Türkiye,” stated that Belgium and Türkiye are natural partners in the field of life sciences, that both countries share the same priorities in supporting innovation and providing better healthcare services to their citizens, and that strong ties to be established between academia and industry, particularly in areas such as rare diseases, would yield concrete outcomes. He also emphasized the importance of collaborations to be developed between Türkiye and Belgium in the field of biopharma.


The program, which brought together many distinguished figures from academia, the healthcare sector and the biopharma industry, concluded with a group photo session.

During the visit of Queen Mathilde of Belgium to Istanbul University, in the closed-door session held in the office of our Rector Prof. Dr. Osman Bülent Zülfikar; representatives of the Turkish Hemophilia Society, Istanbul Faculty of Medicine Division of Neuromuscular Diseases, UCB, Epilepsy Resistant Children Association, Herdem Çare Association, Turkey Rare Diseases Federation, and Muscular Diseases Association of Türkiye were present.


Within the scope of the session, evaluations were made on academic studies in the field of rare diseases, patient support mechanisms, and international collaborations. Queen Mathilde also signed the Istanbul University guest book.


IU Corporate Communications Coordination Office



Photo Gallery

No news found matching the search criteria.